Kyrsten Sinema sued by former bodyguard’s ex-wife over ‘alienation of affection’ | US politics
The ex-wife of Kyrsten Sinema, a former U.S. senator from Arizona, allegedly had a romantic relationship with a member of her security detail that led to the breakdown of the man’s marriage, she alleged in a lawsuit seeking at least $75,000 from Sinema.
Heather Ammel claims that before the theater’s intervention, Matthew and Heather Ammel had a “good and loving marriage” with “true love and affection” and that she pursued Matthew Ammel even though she knew he was married. his case.
According to the lawsuit, the Arizona lawmaker’s security chief hired Matthew Ammel after he retires from the military in 2022; Las Vegas and Saudi Arabia.
In early 2024, Ammel’s wife discovered the “romantic and sensual” messages he had shared with Sinema via the Signal messaging app. The lawsuit alleges that he stopped wearing his wedding ring that summer, and Sinema gave him a job as a national security officer in the Senate office while he continued to work as a bodyguard for her campaign.
According to the lawsuit, the cinema also paid for psychedelic treatment for Ammel, who struggled with post-traumatic stress, substance abuse and traumatic brain injuries due to his military duties in Afghanistan and the Middle East.
Sinema and her attorney did not respond to requests for comment.
The lawsuit was quietly filed late last year in Moore County, North Carolina. This week Sinema asked to move the case from state court to federal court.
North Carolina is one of the few states that allows ex-spouses to file an “alienation of affection” lawsuit to seek compensation from a third party responsible for the dissolution of their marriage.
Sinema left Congress after the 2024 elections. He declined re-election to the Senate, capping a tumultuous single period in which he alienated liberals and left the Democratic party to become an independent.
He currently works for Hogan Lovells, a Washington-based law and lobbying firm. He lobbied for data center development and research funding for the psychedelic drug ibogaine.
